Who says we can't look pretty AND teach & learn at the same time? This Registered Health Information Administrator and Educator sets the societal norms on THIS page, my dear!
Thanks for stopping by!!!!!!
Since the U.S. Food & Drug Administration's (FDA) announcement on November 19, 2010, there's a drug on the market called, "Xgeva" (denosumab), which is prescribed for the treatment of skeletal-related events (SREs) in patients with cancer that has metastasized and damaged bone tissue. Skeletal-related events include bone fractures caused by cancer and bone pain that requires radiation. Xgeva is not approved for patients with multiple myeloma or other cancers of the blood.
Let me know just how much more information you would like to have about this drug ;-)
More Black women are dying! Triple Negative breast cancer is disproportionately killing Black women. Research shows an unequal receipt of "prompt, high-quality treatment" for Black women, compared to White women. Recent studies also report a 77% survival rate among Black women, compared to a 90% survival rate of White women.
Triple Negative breast cancer, an invasive ductal carcinoma, which grows and spreads faster than other types of breast cancers. Triple Negative breast cancer is more common and more aggressive in younger Black women. It is difficult to treat, as hormone therapy and certain (HER2 targeted) drugs have proven to be ineffective, and chemotherapy is possibly a necessary treatment option.
Please take the time to self-examine your breasts every month. Self examination should begin no later than your 20th birthday. If you're unsure about how to examine your breasts, ask your health care provider or visit the nearest health department. Also ask about early screening options, such as mammogram, clinical breast exam, ultrasound, and MRI or Magnetic Resonance Imaging.
***Get more information at www.sistersnetworkinc.org***
Breast health awareness. (2009). Guidelines for early detection [Brochure]. Sisters of Network, Inc.: Author
